NTNX delivers steady growth in product revenues in first-quarter fiscal 2025, driven by expanding partnerships and demand for ...

Nutanix's (NTNX) stock fell about 6% on Wednesday, despite a fiscal first quarter beat and analysts maintaining bullish views ...

Nutanix reported quarterly earnings of 42 cents per share which beat the analyst consensus estimate of 31 cents per share.

Symbotic Inc. (SYM) stock is plunging by 40% at the time of this video's posting after delaying its 10K report to the ...

Nutanix, Inc. ($NTNX), a hybrid multi-cloud computing company, announced better-than-expected fiscal-year 2025 first-quarter ...

Infrastructure software company Nutanix reported first-quarter results that beat expectations and gave an outlook that is ...

SAN JOSE, Calif., Nov. 27, 2024 (GLOBE NEWSWIRE) -- Nutanix, Inc. (NASDAQ: NTNX ), a leader in hybrid multicloud computing, today announced that its management will present at the following upcoming ...

Needham raised the firm’s price target on Nutanix (NTNX) to $90 from $80 and keeps a Buy rating on the shares. Nutanix reported a strong ...

Nutanix Q1 Results Highlight Strong Customer Growth but Slowing ARR and Federal Vertical Weakness, Analysts Remain Cautious.

Highlights:,U.S. stock futures show slight gains ahead of Thanksgiving, with major indexes poised for mixed action.,Tech ...

Delivers Outperformance Across All First Quarter Guided Metrics Reports 18% YoY ARR Growth and Strong Free Cash Flow SAN JOSE, Calif., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Nutanix, Inc. (NASDAQ: NTNX), ...

Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer ...